Press release
Schizophrenia Drugs Market by Top Key Players are H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Janssen Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca, ALLERGAN, OTHERS
The increasing prevalence of chronic and mental disorder is a key factor expected to enable growth in the global schizophrenia drugs market, says Fortune Business Insights in a report, titled "Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026." The global schizophrenia drugs market was valued at USD 6.75 Billion in 2018 and is projected to reach USD 9.48 Billion by 2026, exhibiting a CAGR of 4.3% during the forecast period.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/schizophrenia-drugs-market-101531
Rising Awareness About Mental Disorders Will Boost Growth
According to Fortune Business Insights, the increasing cases of mental disorders such as schizophrenia will uplift the global schizophrenia drugs market shares. The surge in medical interventions for the treatment of major mental disorders will enable growth in the global schizophrenia drugs market during the forecast period. Furthermore, the rising emphasis on mental illness and mental health in emerging nations will boost the global schizophrenia drugs market revenue during the forecast period. Moreover, the increasing efficacy and safety features of treatment for schizophrenia will fuel demand among patients which,will in turn, accelerate the growth of the global schizophrenia drugs.
Order Single or Corporate User License Copy@ https://www.fortunebusinessinsights.com/checkout-page/101531
Some of the Leading Players Operating In The Global Schizophrenia Drugs Market Involve:
o H. Lundbeck A/S
o Otsuka Pharmaceutical Co., Ltd.
o Janssen Pharmaceuticals, Inc.
o Eli Lilly and Company
o AstraZeneca
o ALLERGAN
o Vanda Pharmaceuticals Inc.
o Sumitomo Dainippon Pharma Co., Ltd.
o Alkermes plc
o Bristol-Myers Squibb Company
Key Segmentation of Schizophrenia Drugs Market:
Schizophrenia Drugs Market Segments by Therapeutic Class
o Second Generation
o Third Generation
o Others
Schizophrenia Drugs Market Segments by Treatment
o Oral
o Injectable
Schizophrenia Drugs Market Segments by Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
o Others
By Geography
o North America (U.S. and Canada)
o Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
o Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
o Latin America (Brazil, Mexico, and Rest of Latin America)
o Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Launch Of REXULTI Tablets Will Propel Growth
Otsuka Pharmaceutical Co., Ltd., a pharmaceutical company headquartered in Tokyo launched REXULTI Tablets (chemical name is brexpiprazole) in 1 mg and 2 mg tablets for the treatment of schizophrenia in patients. Based on the efficacy of REXULTI in the treatment of schizophrenia, it is included in the Japanese National Health Insurance Drug Price List. The launch of REXULTI
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/schizophrenia-drugs-market-101531
Rising Awareness About Mental Disorders Will Boost Growth
According to Fortune Business Insights, the increasing cases of mental disorders such as schizophrenia will uplift the global schizophrenia drugs market shares. The surge in medical interventions for the treatment of major mental disorders will enable growth in the global schizophrenia drugs market during the forecast period. Furthermore, the rising emphasis on mental illness and mental health in emerging nations will boost the global schizophrenia drugs market revenue during the forecast period. Moreover, the increasing efficacy and safety features of treatment for schizophrenia will fuel demand among patients which,will in turn, accelerate the growth of the global schizophrenia drugs.
Order Single or Corporate User License Copy@ https://www.fortunebusinessinsights.com/checkout-page/101531
Some of the Leading Players Operating In The Global Schizophrenia Drugs Market Involve:
o H. Lundbeck A/S
o Otsuka Pharmaceutical Co., Ltd.
o Janssen Pharmaceuticals, Inc.
o Eli Lilly and Company
o AstraZeneca
o ALLERGAN
o Vanda Pharmaceuticals Inc.
o Sumitomo Dainippon Pharma Co., Ltd.
o Alkermes plc
o Bristol-Myers Squibb Company
Key Segmentation of Schizophrenia Drugs Market:
Schizophrenia Drugs Market Segments by Therapeutic Class
o Second Generation
o Third Generation
o Others
Schizophrenia Drugs Market Segments by Treatment
o Oral
o Injectable
Schizophrenia Drugs Market Segments by Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
o Others
By Geography
o North America (U.S. and Canada)
o Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
o Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
o Latin America (Brazil, Mexico, and Rest of Latin America)
o Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Launch Of REXULTI Tablets Will Propel Growth
Otsuka Pharmaceutical Co., Ltd., a pharmaceutical company headquartered in Tokyo launched REXULTI Tablets (chemical name is brexpiprazole) in 1 mg and 2 mg tablets for the treatment of schizophrenia in patients. Based on the efficacy of REXULTI in the treatment of schizophrenia, it is included in the Japanese National Health Insurance Drug Price List. The launch of REXULTI
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
